main content start

MedEnrich | Página principal

Continue Watching

últimos vidéos

últimos vidéos

Brightcove Home Latest Listing

Cáncer de mama

Cáncer de mama

Brightcove Cards Listing

Cáncer de próstata

Brightcove Cards Listing

Mieloma múltiple

Mieloma múltiple

Brightcove Cards Listing

Popular en MedEnrich

Popular in Sin nombre
  • Myelodysplastic Syndromes14m 13s

    ASH 2022 Update on Myelodysplastic Syndromes

    ASH 2022 - Update on Myelodysplastic Syndromes
    eln classification low risk mds low dose lenalidomide venetoclax viale -a tags: azacitidine
  • Cancer de prostata6m 59s

    Managing Nonmetastatic Castration-Resistant Prostate Cancer (nmCRPC)

    3 randomized clinical trials (SPRATAN- Apalutamide), (PROSPER -Enzalutamide) & (ARAMIS -Darolutamide) have shown consistent and almost similar benefit in Metastasis Free Survival in nmCRPC
    nmcrpc metastasis free survival spartan prosper & aramis clinical trial
  • Mieloma múltiple9m 20s

    Integrating Pomalidomide Based Regimens in Multiple Myeloma

    Integrating pomalidomide and dexamethasone in the treatment of relapsed or refractory multiple myeloma (RRMM) involves using them as a core regimen, often combined with other agents like bortezomib or monoclonal antibodies for enhanced efficacy.
    pomalidomide-dexamethasone rrmm management progression-free survival combination therapies
  • nasopharyngeal carcinoma44m 35s

    Comprehensive Overview of Nasopharyngeal Carcinoma

    Over the last few years treatment of Nasopharyngeal Carcinoma has evolved with minimally invasive surgery, advances in chemotherapy & immunotherapy.
    nasopharyngeal carcinoma immunotherapy
  • Cáncer de mama3m 56s

    Duration of trastuzumab in patients with Her2 positive Metastatic Breast Cancer in prolonged remission

    There are no randomized clinical trials addressing the continued use of Trastuzumab for Her2 positive MBC patients in prolonged remission and has become important and relevant clinical question.
    her2 positive mbc prolonged remission trastuzumab duration
  • Acute Myeloid Leukaemia12m 22s

    EHA 2022 Updates : AML

    EHA Updates AML : QuANTUM phase 3 study showed significant overall survival in adults having FLT3-ITD+ acute myeloid leukaemia with  addition of quizartinib to standard induction and consolidation therapy alone.
    aml decitabine g-csf hypomethylating agents
  • Oncospecials14m 58s

    Is TKI Monotherapy still relevant for advanced Renal Cell carcinoma

    ICIs in combination with VEGF-targeted treatments have become standard of care in 1st line advanced RCC ,however there are certain group of patients wherein treatment with single agent TKI can still be considered optimal
    1st line rcc single agent tki
  • Oncospecials4m 33s

    Case of Advanced Renal Cell Carcinoma patient with Rheumatoid Arthritis treated with single agent TKI

    Learn about successful treatment of 72 year old Renal Cell Carcinoma Patient also suffering from Rheumatoid Arthritis treated with single agent TKI
    renal cell carcinoma rheumatoid arthritis single agent tki
  • Cáncer de mama8m 50s

    Immunotherapy of Early Breast Cancer

    I-SPY2 clinical trial laid the foundation for Immunotherapy in Early Breast Cancer with Pembrolizumab added to Neoadjuvant Chemotherapy.
    keynote -522 immunotherapy early breast cancer
  • Oncology9m 34s

    Case Based Learning in Cardio Oncology

    Immunotherapy mediated cardiotoxicity like myocarditis & cardiovascular issues arising of cytokine release syndrome can become more common with increasing adoption of Immunotherapy in cancer treatment.
    car-t cell therapy cytokine release syndrome immunotherapy mediated myocarditis

Seminarios web anteriores

Seminarios web anteriores

Webinar Cards Listing

Artículos

Artículos

Medbytes Cards Listing
Hi, can I help?
Chat de ayudaX
Equipo de soporte
¡Hola! ¿Cómo puedo ayudarlo/a hoy?
Por favor seleccione alguna de las siguientes opciones.

Buscar información

Problemas con el inicio de sesión o registro

Compartir un comentario